Cytotoxic T Lymphocytes Elicited by Dendritic Cell-Targeted Delivery of Human Papillomavirus Type-16 E6/E7 Fusion Gene Exert Lethal Effects on CaSki Cells |
Wu, Xiang-Mei
(Chongqing Molecular Medicine and Cancer Research Center, Chongqing Children's Hospital)
Liu, Xing (Department of Pediatric Urology, Chongqing Children's Hospital) Jiao, Qing-Fang (Chongqing Molecular Medicine and Cancer Research Center, Chongqing Children's Hospital) Fu, Shao-Yue (Chongqing Molecular Medicine and Cancer Research Center, Chongqing Children's Hospital) Bu, You-Quan (Chongqing Molecular Medicine and Cancer Research Center, Chongqing Children's Hospital) Song, Fang-Zhou (Chongqing Molecular Medicine and Cancer Research Center, Chongqing Children's Hospital) Yi, Fa-Ping (Chongqing Molecular Medicine and Cancer Research Center, Chongqing Children's Hospital) |
1 | Munger K, Basile J, Duensing S, et al (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-98. DOI |
2 | Zur Hausen H (1996). Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta, 1228, F55-78. |
3 | zur Hausen H (2000). Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst, 92, 690-8. DOI ScienceOn |
4 | Sufang Wu, Li Meng, Shixuan Wang, et al (2006). Reversal of the malignant phenotype of cervical cancer CaSki Cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA. Clin Cancer Res, 12, 2032-7. DOI ScienceOn |
5 | Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9. DOI |
6 | Watanabe S, Kagamu H, Yoshizawa H, et al (2003). The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. J Immunol, 171, 5828-36. DOI |
7 | Parkin DM, Bray F (2006). The burden of HPV-related cancers. Vaccine, 24, 11-25. |
8 | Steinman RM, Nussenzweig MC (2002). Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA, 99, 351-8. DOI ScienceOn |
9 | Werness BA, Levine AJ, Howley PM (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-9. DOI |
10 | Wheeler CM (2007). Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol, 4, 224-35. DOI ScienceOn |
11 | Young A (2010). HPV vaccine acceptance among women in the Asian Pacific: a systematic review of the literature. Asian Pac J Cancer Prev, 11, 641-9. |
12 | Zeng Q, Peng S, Monie A, et al (2011). Control of ervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents. Hum Gene Ther, 22, 809-19. DOI ScienceOn |
13 | Levine AJ (1997). P53, the cellular gatekeeper for growth and division. Cell, 88, 323-31. DOI ScienceOn |
14 | Liu Z, Xu X, Hsu HC, et al (2003). CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CIIinduced arthritis. J Clin Invest, 112, 1332-41. DOI |
15 | Evan G, Littlewood T (1998). A matter of life and cell death. Science, 281, 1317-22. DOI ScienceOn |
16 | Frazer IH, Quinn M, Nicklin JL, et al (2004). Phase I study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. Vaccine, 23, 172-181. DOI ScienceOn |
17 | Koutsky LA, Harper DM (2006). Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine, 24, 114-21. DOI ScienceOn |
18 | Lu L, Lee WC, Takayama T, et al (1999). Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-, and CTLA4Ig). J Leukocyte Biol, 66, 293-6. |
19 | Matsue H, Matsue K, Walters M, et al (1999). Induction of antigen-specific immunosuppression by CD95L cDNAtransfected 'killer' dendritic cells. Nat Med, 5, 930-7. DOI ScienceOn |
20 | Milde-Langosch K, Riethdorf S, Loning T (2000). Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications. Virchows Arch, 437, 227-33. DOI ScienceOn |
21 | Morelli AE, Thomson AW (2003). Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev, 196, 125-46. DOI ScienceOn |
22 | Morita Y, Yang J, Gupta R, et al (2001). Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest, 107, 1275-84. DOI ScienceOn |
23 | Chen Z, Kamath P, Zhang S, et al (1996). Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18. Cancer Gene Ther, 3, 18-23. |
24 | Banchereau J, Briere F, Caux C, et al (2000). Immunobiology of dendritic cells. Annu Rev Immunol, 18, 767-811. DOI ScienceOn |
25 | Barrios K, Celis E (2012). TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers. Cancer Immunol Immunother, 61, 1307-17. DOI |